These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2482512)

  • 1. Captopril and capsaicin modify opioid withdrawal in the morphine-dependent rat.
    Sharpe LG; Jaffe JH
    Pharmacol Biochem Behav; 1989 Aug; 33(4):899-902. PubMed ID: 2482512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neonatal capsaicin modifies morphine withdrawal signs in the rat.
    Sharpe LG; Jaffe JH
    Neurosci Lett; 1986 Nov; 71(2):213-8. PubMed ID: 2431361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary sensory neurones and naloxone-precipitated morphine withdrawal.
    Donnerer J
    Br J Pharmacol; 1989 Apr; 96(4):767-72. PubMed ID: 2472843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The contribution of supraspinal, peripheral and intrinsic spinal circuits to the pattern and magnitude of Fos-like immunoreactivity in the lumbar spinal cord of the rat withdrawing from morphine.
    Rohde DS; McKay WR; Chang DS; Abbadie C; Basbaum AI
    Neuroscience; 1997 Sep; 80(2):599-612. PubMed ID: 9284361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of morphine withdrawal signs in the rat after chronic treatment with naloxone.
    Suzuki T; Fukagawa Y; Misawa M
    Eur J Pharmacol; 1990 Mar; 178(2):239-42. PubMed ID: 2158457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RP 67580, a selective antagonist of neurokinin-1 receptors, modifies some of the naloxone-precipitated morphine withdrawal signs in rats.
    Maldonado R; Girdlestone D; Roques BP
    Neurosci Lett; 1993 Jun; 156(1-2):135-40. PubMed ID: 7692360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrophysiological evidence for a presynaptic mechanism of morphine withdrawal in the neonatal rat spinal cord.
    Bell JA; Jaffe JH
    Brain Res; 1986 Sep; 382(2):299-304. PubMed ID: 2428442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Capsaicin pretreatment does not inhibit the opioid withdrawal response in guinea-pigs.
    Chahl LA
    Eur J Pharmacol; 1988 Dec; 158(1-2):91-8. PubMed ID: 3220120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ibogaine fails to reduce naloxone-precipitated withdrawal in the morphine-dependent rat.
    Sharpe LG; Jaffe JH
    Neuroreport; 1990 Sep; 1(1):17-9. PubMed ID: 2129850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma malondialdehyde levels and opiate withdrawal signs observed in rats treated with morphine plus naloxone: effects of alpha-lipoic acid administration.
    Pinelli A; Cighetti G; Trivulzio S
    Fundam Clin Pharmacol; 2008 Aug; 22(4):439-45. PubMed ID: 18705754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of sacral spinal cord neurons to the autonomic and somatic consequences of withdrawal from morphine in the rat.
    Rohde DS; McKay WR; Abbadie C; Basbaum AI
    Brain Res; 1997 Jan; 745(1-2):83-95. PubMed ID: 9037396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of delta-opioid receptors in mediating the aversive stimulus effects of morphine withdrawal in the rat.
    Funada M; Schutz CG; Shippenberg TS
    Eur J Pharmacol; 1996 Apr; 300(1-2):17-24. PubMed ID: 8741160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opiate withdrawal-induced hyposensitivity to naloxone's effects on serum luteinizing hormone in the male rat.
    Cicero TJ; Aleem A; Meyer ER; Schmoeker PF; Miller BT
    J Pharmacol Exp Ther; 1986 Sep; 238(3):1063-70. PubMed ID: 3528453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain reward deficits accompany naloxone-precipitated withdrawal from acute opioid dependence.
    Liu J; Schulteis G
    Pharmacol Biochem Behav; 2004 Sep; 79(1):101-8. PubMed ID: 15388289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conditioning processes contribute to severity of naloxone-precipitated withdrawal from acute opioid dependence.
    Schulteis G; Morse AC; Liu J
    Psychopharmacology (Berl); 2004 Oct; 175(4):463-72. PubMed ID: 15083263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dorsal noradrenergic bundle lesions fail to alter opiate withdrawal or suppression of opiate withdrawal by clonidine.
    Britton KT; Svensson T; Schwartz J; Bloom FE; Koob GF
    Life Sci; 1984 Jan; 34(2):133-9. PubMed ID: 6537983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Activation of the spinal extracellular signal-regulated kinase is involved in morphine dependence and naloxone-precipitated withdrawal response].
    He JH; Cao JL; Xu YB; Song XS; Ding HL; Zeng YM
    Sheng Li Xue Bao; 2005 Oct; 57(5):557-65. PubMed ID: 16220193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of aging on morphine withdrawal in the rat.
    Simpkins JW
    Exp Gerontol; 1994; 29(1):67-76. PubMed ID: 8187842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonist-precipitated opioid withdrawal in rats: evidence for dissociations between physical and motivational signs.
    Higgins GA; Sellers EM
    Pharmacol Biochem Behav; 1994 May; 48(1):1-8. PubMed ID: 8029278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of different brain structures in the expression of the physical morphine withdrawal syndrome.
    Maldonado R; Stinus L; Gold LH; Koob GF
    J Pharmacol Exp Ther; 1992 May; 261(2):669-77. PubMed ID: 1578378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.